---
title: 'Diagnosis and management of pancreatic insufficiency in patients with gastrectomy
  due to cancer or gastric ulcers: a virtual roundtable expert discussion'
date: '2023-12-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38108090/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231219170639&v=2.18.0
source: heidelberg[Affiliation]
description: 'INTRODUCTION: Pancreatic exocrine insufficiency (PEI) is common after
  gastric resection for cancer or ulcers but is under-recognized and undertreated.
  Although pancreatic enzyme replacement therapy (PERT) is the mainstay of PEI management,
  robust evidence supporting its use after gastric surgery is ...'
disable_comments: true
---
INTRODUCTION: Pancreatic exocrine insufficiency (PEI) is common after gastric resection for cancer or ulcers but is under-recognized and undertreated. Although pancreatic enzyme replacement therapy (PERT) is the mainstay of PEI management, robust evidence supporting its use after gastric surgery is ...